0.017
0.00 (-8.56%)
| Penutupan Terdahulu | 0.019 |
| Buka | 0.018 |
| Jumlah Dagangan | 96,418 |
| Purata Dagangan (3B) | 520,307 |
| Modal Pasaran | 1,296,898 |
| Harga / Pendapatan (P/E TTM) | 0.190 |
| Harga / Jualan (P/S) | 2.11 |
| Harga / Buku (P/B) | 33.49 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 18 Aug 2025 - 22 Aug 2025 |
| Margin Operasi (TTM) | -18,553.67% |
| EPS Cair (TTM) | 0.090 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -96.40% |
| Nisbah Semasa (MRQ) | 0.140 |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.67 M |
| Pulangan Atas Aset (ROA TTM) | -62.52% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Menurun | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Menurun | Bercampur | |
| Stok | CAN B CORP. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | -1.00 |
|
Can B Corp., a health and wellness company, develops, manufactures, and sells hemp derived products in the United States. The company provides CBD products derived from hemp, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and lifestyle products. It sells its products under the Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil brands through medical professionals, website, and vending machines. The company also produces industrial hemp, and processes hemp biomass, isolate, and isomers, such as CBN, CBG, delta-8, and delta-10; and manufactures and sells durable medical equipment. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in February 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| % Dimiliki oleh Orang Dalam | 3.48% |
| % Dimiliki oleh Institusi | 0.98% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 10 Apr 2025 | Pengumuman | Can B Corp.'s Nascent Pharma Hires Fox Rothschild to Defend and Monetize Its Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |